# A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamic Effects of MEDI5884 in Adults With Stable Coronary Heart Disease

> **NCT03351738** · PHASE2 · COMPLETED · sponsor: **MedImmune LLC** · enrollment: 133 (actual)

## Conditions studied

- Stable Coronary Heart Disease

## Interventions

- **DRUG:** MEDI5884
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03351738
- **Lead sponsor:** MedImmune LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-12-13
- **Primary completion:** 2018-11-09
- **Final completion:** 2018-11-09
- **Target enrollment:** 133 (ACTUAL)
- **Last updated:** 2020-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03351738

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03351738, "A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamic Effects of MEDI5884 in Adults With Stable Coronary Heart Disease". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT03351738. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*